Pages that link to "Q80050896"
Jump to navigation
Jump to search
The following pages link to Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation (Q80050896):
Displaying 50 items.
- Cell biology and genetics of minimal change disease (Q26752464) (← links)
- Matrix metalloproteinase 1: role in sarcoma biology (Q27315973) (← links)
- Acoustic driven flow and lattice Boltzmann simulations to study cell adhesion in biofunctionalized mu-fluidic channels with complex geometry (Q30480062) (← links)
- Platelet granule secretion continuously prevents intratumor hemorrhage (Q30483704) (← links)
- Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes (Q30484244) (← links)
- MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation. (Q30495880) (← links)
- A novel method of differential gene expression analysis using multiple cDNA libraries applied to the identification of tumour endothelial genes (Q33327177) (← links)
- Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions (Q33665623) (← links)
- Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapy (Q34048965) (← links)
- Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis. (Q34457039) (← links)
- Mechanism of down-regulation of RNA polymerase III-transcribed non-coding RNA genes in macrophages by Leishmania (Q34675826) (← links)
- Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy (Q35083186) (← links)
- Collagenolytic matrix metalloproteinases in chronic obstructive lung disease and cancer (Q35237516) (← links)
- Increased expression of protease-activated receptor 4 and Trefoil factor 2 in human colorectal cancer (Q35394268) (← links)
- Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer (Q35941710) (← links)
- Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease (Q36009930) (← links)
- A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in sepsis. (Q36088900) (← links)
- Matrix metalloprotease-1a promotes tumorigenesis and metastasis (Q36097959) (← links)
- Matrix metalloproteinase-1-mediated up-regulation of vascular endothelial growth factor-2 in endothelial cells (Q36508733) (← links)
- Matrix metalloproteinase-1 promotes prostate tumor growth and metastasis. (Q36538338) (← links)
- Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins (Q36644577) (← links)
- Silver nanoparticle-enriched diamond-like carbon implant modification as a mammalian cell compatible surface with antimicrobial properties (Q36666774) (← links)
- Proteases as modulators of tumor-stromal interaction: primary tumors to bone metastases (Q36707418) (← links)
- Leukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization (Q36715904) (← links)
- Matrix metalloproteinase 8 (collagenase 2) induces the expression of interleukins 6 and 8 in breast cancer cells (Q36910024) (← links)
- Matrix metalloproteinase-1 and thrombin differentially activate gene expression in endothelial cells via PAR-1 and promote angiogenesis (Q37061090) (← links)
- Combined upregulation of matrix metalloproteinase-1 and proteinase-activated receptor-1 predicts unfavorable prognosis in human nasopharyngeal carcinoma (Q37125603) (← links)
- Tumor MMP-1 activates endothelial PAR1 to facilitate vascular intravasation and metastatic dissemination (Q37125854) (← links)
- Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model (Q37169198) (← links)
- Protease-activated receptor-1 deficiency protects against streptozotocin-induced diabetic nephropathy in mice (Q37251378) (← links)
- Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis (Q37322052) (← links)
- Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer (Q37326414) (← links)
- Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents (Q37406706) (← links)
- Matrix metalloproteinase and G protein coupled receptors: co-conspirators in the pathogenesis of autoimmune disease and cancer (Q37439490) (← links)
- Heparins that block VEGF-A-mediated von Willebrand factor fiber generation are potent inhibitors of hematogenous but not lymphatic metastasis (Q37708829) (← links)
- Tissue factor and cell signalling in cancer progression and thrombosis (Q37903955) (← links)
- Metastasis review: from bench to bedside (Q38237985) (← links)
- Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity (Q38902935) (← links)
- Proteinase-activated receptors 1 and 2 regulate invasive behavior of human melanoma cells via activation of protein kinase D1. (Q39459192) (← links)
- Investigation of the essential role of platelet-tumor cell interactions in metastasis progression using an agent-based model (Q39649606) (← links)
- The mechanism of melanoma-associated thrombin activity and von Willebrand factor release from endothelial cells (Q39699871) (← links)
- Matrix Metalloproteinase 1 Causes Vasoconstriction and Enhances Vessel Reactivity to Angiotensin II via Protease-Activated Receptor 1. (Q40464605) (← links)
- von Willebrand factor fibers promote cancer-associated platelet aggregation in malignant melanoma of mice and humans (Q40671371) (← links)
- MMP9 processing of HSPB1 regulates tumor progression (Q41880269) (← links)
- Dabigatran potentiates gemcitabine-induced growth inhibition of pancreatic cancer in mice (Q42314537) (← links)
- Interleukin 8 is differently expressed and modulated by PAR-1 activation in early and late endothelial progenitor cells. (Q42439415) (← links)
- New tools for assessing the individual risk of metastasis in renal cell carcinoma. (Q44540214) (← links)
- Invasion patterns and metastasis of urothelial carcinoma. A challenge for translational research (Q46425203) (← links)
- Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer (Q47113157) (← links)
- Plasmin reduces fibronectin deposition by mesangial cells in a protease-activated receptor-1 independent manner (Q47142090) (← links)